Biogen

In News

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026 - Biogen

Biogen - Jul 12, 2026

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters

Reuters - Jul 13, 2026

Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details - Barron's

Barron's - Jul 13, 2026

All eyes on data on Biogen’s tau therapy - STAT

STAT - Jul 13, 2026

American Express, Biogen upgraded: Wall Street's top analyst calls - Yahoo Finance

Yahoo Finance - Jul 13, 2026

Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch - Jul 13, 2026

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug | Business Information & News | FE - Westlaw Today

Westlaw Today - Jul 14, 2026

Eisai and Biogen Announce FDA Approval of LEQEMBI IQLIK as First At-Home Initiation Dose for Early Alzheimer’s Disease - Quiver Quantitative

Quiver Quantitative - Jul 13, 2026

Why is Biogen stock rallying today? - Investing.com

Investing.com - Jul 13, 2026

FDA approves at-home starter dose of Eisai-Biogen Alzheimer’s drug - PharmaLive

PharmaLive - Jul 13, 2026

A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03 - GuruFocus

GuruFocus - Jul 13, 2026

Biogen Inc.’s stock price soars to $209.03, marking a bullish 4.96% surge - Smartkarma

Smartkarma - Jul 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment